{"title":"摇头丸初次戒断药物依赖者和MDMA使用者的认知功能。","authors":"Adam Potter, Luke Downey, Con Stough","doi":"10.2174/1874473711306010008","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction/aims: </strong>'Hidden' symptoms, or subtle cognitive deficits and long-term changes in mood, have been linked to the recreational use of 3, 4-methylenedioxymethamphetamine/MDMA, and are notionally present in non-heavy polydrug users. This study assessed the cognitive functioning and mood profiles of clinically diagnosed drug dependents who had never consumed MDMA, recreational drug users that had previously consumed MDMA, with both groups having not consumed illicit drugs for 6-months, and a control group with limited illicit drug use and no MDMA usage in their past.</p><p><strong>Methods: </strong>Cognitive functioning was assessed using the Cognitive Drug Research computerised cognitive assessment system and participants completed the Profile of Mood States and Beck Depression Inventory to assess their current mood and depression.</p><p><strong>Results: </strong>Participants in the clinically diagnosed drug dependent group scored significantly worse on the 'Quality of Working Memory' cognitive factor score than both the MDMA and control group (F (2, 33) = 5.75, p = 0.007). The control and clinical groups also differed on depression scores (U [16] = 13.00, p = 0.016) and Tension/Anxiety scores (U [16] = 16.00, p = 0.034), with the clinical group scoring significantly higher in both cases. The MDMA group did not differ from the control group on the measures of cognition or mood.</p><p><strong>Discussion/conclusions: </strong>These results suggest that despite a 6-month prolonged abstinence the cognitive deficits ostensibly caused by 'heavy' usage or the dependence on or abuse of illicit drugs are not reversed by abstinence.</p>","PeriodicalId":72730,"journal":{"name":"Current drug abuse reviews","volume":"6 1","pages":"71-6"},"PeriodicalIF":0.0000,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874473711306010008","citationCount":"9","resultStr":"{\"title\":\"Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.\",\"authors\":\"Adam Potter, Luke Downey, Con Stough\",\"doi\":\"10.2174/1874473711306010008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction/aims: </strong>'Hidden' symptoms, or subtle cognitive deficits and long-term changes in mood, have been linked to the recreational use of 3, 4-methylenedioxymethamphetamine/MDMA, and are notionally present in non-heavy polydrug users. This study assessed the cognitive functioning and mood profiles of clinically diagnosed drug dependents who had never consumed MDMA, recreational drug users that had previously consumed MDMA, with both groups having not consumed illicit drugs for 6-months, and a control group with limited illicit drug use and no MDMA usage in their past.</p><p><strong>Methods: </strong>Cognitive functioning was assessed using the Cognitive Drug Research computerised cognitive assessment system and participants completed the Profile of Mood States and Beck Depression Inventory to assess their current mood and depression.</p><p><strong>Results: </strong>Participants in the clinically diagnosed drug dependent group scored significantly worse on the 'Quality of Working Memory' cognitive factor score than both the MDMA and control group (F (2, 33) = 5.75, p = 0.007). The control and clinical groups also differed on depression scores (U [16] = 13.00, p = 0.016) and Tension/Anxiety scores (U [16] = 16.00, p = 0.034), with the clinical group scoring significantly higher in both cases. The MDMA group did not differ from the control group on the measures of cognition or mood.</p><p><strong>Discussion/conclusions: </strong>These results suggest that despite a 6-month prolonged abstinence the cognitive deficits ostensibly caused by 'heavy' usage or the dependence on or abuse of illicit drugs are not reversed by abstinence.</p>\",\"PeriodicalId\":72730,\"journal\":{\"name\":\"Current drug abuse reviews\",\"volume\":\"6 1\",\"pages\":\"71-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1874473711306010008\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current drug abuse reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874473711306010008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug abuse reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874473711306010008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9
摘要
介绍/目的:“隐性”症状,或微妙的认知缺陷和情绪的长期变化,与娱乐性使用3,4 -亚甲基二氧甲基苯丙胺/MDMA有关,并且在非重度多种药物使用者中理论上存在。本研究评估了临床诊断为从未服用过MDMA的药物依赖者和之前服用过MDMA的娱乐性药物使用者的认知功能和情绪特征,两组都有6个月没有服用非法药物,对照组有有限的非法药物使用,过去没有使用过MDMA。方法:采用认知药物研究计算机化认知评估系统对参与者的认知功能进行评估,并完成情绪状态量表和贝克抑郁量表来评估他们当前的情绪和抑郁状况。结果:临床诊断为药物依赖组的“工作记忆质量”认知因子得分明显低于MDMA组和对照组(F (2,33) = 5.75, p = 0.007)。对照组和临床组在抑郁评分(U [16] = 13.00, p = 0.016)和紧张/焦虑评分(U [16] = 16.00, p = 0.034)上也存在差异,临床组和对照组得分均显著高于对照组。在认知和情绪方面,服用MDMA的小组与对照组没有什么不同。讨论/结论:这些结果表明,尽管有6个月的长期戒断,但表面上由“大量”使用或依赖或滥用非法药物引起的认知缺陷并没有被戒断所逆转。
Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
Introduction/aims: 'Hidden' symptoms, or subtle cognitive deficits and long-term changes in mood, have been linked to the recreational use of 3, 4-methylenedioxymethamphetamine/MDMA, and are notionally present in non-heavy polydrug users. This study assessed the cognitive functioning and mood profiles of clinically diagnosed drug dependents who had never consumed MDMA, recreational drug users that had previously consumed MDMA, with both groups having not consumed illicit drugs for 6-months, and a control group with limited illicit drug use and no MDMA usage in their past.
Methods: Cognitive functioning was assessed using the Cognitive Drug Research computerised cognitive assessment system and participants completed the Profile of Mood States and Beck Depression Inventory to assess their current mood and depression.
Results: Participants in the clinically diagnosed drug dependent group scored significantly worse on the 'Quality of Working Memory' cognitive factor score than both the MDMA and control group (F (2, 33) = 5.75, p = 0.007). The control and clinical groups also differed on depression scores (U [16] = 13.00, p = 0.016) and Tension/Anxiety scores (U [16] = 16.00, p = 0.034), with the clinical group scoring significantly higher in both cases. The MDMA group did not differ from the control group on the measures of cognition or mood.
Discussion/conclusions: These results suggest that despite a 6-month prolonged abstinence the cognitive deficits ostensibly caused by 'heavy' usage or the dependence on or abuse of illicit drugs are not reversed by abstinence.